Table of Contents Table of Contents
Previous Page  182 / 220 Next Page
Information
Show Menu
Previous Page 182 / 220 Next Page
Page Background

TABLE 2. Univariate analysis of outcome predictors.

Overall

HPV negative

HPV positive

Variables

HR

95% CI

p

value

No. of

patients

HR

95% CI

p

value

No. of

patients

HR

95% CI

p

value

No. of

patients

Age, y

1.027

1.006–1.05

.0129

295

1.023 0.997–1.050 .0871

117

1.011 0.974–1.050 .5602

171

Approach

Transoral

Ref

Ref

Ref

Open

2.732 1.822–4.096

<

.0001

296

1.449 0.865–2.426 .1589

117

3.899 1.964–7.742 .0001

172

Extranodal extension

No

Ref

Ref

Ref

Yes

2.364 1.582–3.532

<

.0001

286

2.396 1.432–4.010 .0009

111

1.921 0.985–3.744 .0553

169

HPV

Positive

Ref

Negative

3.393 2.255–5.106

<

.0001

289

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Marital status

Married

Ref

Ref

Ref

Single/divorced/widowed 1.625 1.064–2.481

.0247

275

1.671 0.963–2.898 .0680

104

1.203 0.595–2.433 .6067

164

Mucosal margins

Free of carcinoma

Ref

Ref

Ref

Positive

1.591 1.005–2.517

.0473

293

1.317 0.727–2.387 .3640

116

1.775 0.828–3.806 .1401

170

N classification

N0/N1

Ref

Ref

Ref

N2/N3

1.059 0.701–1.600

.7849

294

1.385 0.836–2.294 .2064

117

1.057 0.508–2.200 .8817

171

p16 status

Positive

Ref

Negative

2.983 1.999–4.453

<

.0001

288

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Perineural invasion

No

Ref

Ref

Ref

Yes

2.453 1.653–3.642

<

.0001

291

1.806 1.102–2.958 .0190

116

1.884 0.920–3.858 .0831

168

Primary site

BOT

Ref

Ref

Ref

Other

2.417 1.233–4.739

.0102

2.836 1.323–6.080 .0074

0.561 0.072–4.403 .5828

Tonsil

0.963 0.605–1.533

.8739

295

1.798 0.987–3.274 .0550

117

0.584 0.279–1.221 .1529

171

Race

White

Ref

African American/black

2.556 1.238–5.278

.0112

293

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

HPV risk group

Low

Ref

Intermediate

1.818 0.962–3.438

.0659

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

High

4.801 2.831–8.141

<

.0001

276

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

p16 risk group

Low

Ref

Intermediate

2.322 1.397–3.861

.0012

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

High

4.284 2.590–7.086

<

.0001

275

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Sex

Female

Ref

Ref

Ref

Male

1.223 0.743–2.013

.4292

296

0.949 0.507–1.776 .8691

117

1.268 0.553–2.909 .5752

172

S

URGICAL MANAGEMENT OF OROPHARYNGEAL

SCC

HEAD & NECK—DOI 10.1002/HED APRIL 2016

162